Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Minimed GroupSTU:B8S 20 PS Ratio is 3.36 as of Aug. 28, 2026, which is 26% above its 10-year median of 2.66. GuruFocus rates STU:B8S with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Minimed Group ranks worse than 54.23% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Minimed Group's share price is €16.60.
Minimed Group's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was €4.94. Hence, Minimed Group's PS Ratio for today is 3.36.
Good Sign:
Minimed Group Inc stock PS Ratio (=1.61) is close to 1-year low of 1.61.
The historical rank and industry rank for Minimed Group's PS Ratio or its related term are showing as below:
STU:B8S'
s PS Ratio Range Over the Past 10 Years
Min: 1.86 Med: 2.66 Max: 3.53
Current: 3.37
During the past 4 years, Minimed Group's highest PS Ratio was 3.53. The lowest was 1.86. And the median was 2.66.
STU:B8S's PS Ratio is ranked worse than 54.23% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.985
vs STU:B8S: 3.37
During the past 12 months, the average Revenue per Share Growth Rate of Minimed Group was 25.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 14.80% per year.
During the past 4 years, Minimed Group's highest 3-Year average Revenue per Share Growth Rate was 14.80% per year. The lowest was 14.80% per year. And the median was 14.80% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Minimed Group PS Ratio Related Terms
Minimed Group PS Ratio Historical Data
* Premium members only.
The historical data trend for Minimed Group's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Minimed Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Minimed Group PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Minimed Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where Minimed Group's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Minimed Group's Share Price of today is €16.60. Minimed Group's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.94.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Minimed Group (STU:B8S) has a PS Ratio of 3.36 as of Aug. 28, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Minimed Group and its competitors. This is 26% above median its historical median of 2.66. Over the past decade, Minimed Group's PS Ratio has ranged from 1.86 to 3.53. According to the industry distribution chart, Minimed Group ranks #436 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 54.2%.
Is Minimed Group's PS Ratio too high?
Minimed Group's current PS Ratio of 3.36 is 26% above median its 10-year median of 2.66. Over the past 10 years, this metric has ranged from a low of 1.86 to a high of 3.53. The Medical Devices & Instruments industry median PS Ratio is 2.99. Minimed Group's value of 3.36 is 12.6% above this industry median. Based on the distribution chart, Minimed Group ranks #436 out of 804 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Minimed Group has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's PS Ratio compare to MMSI and NVST?
According to the Medical Devices & Instruments industry distribution chart, Minimed Group ranks #436 out of 804 companies for PS Ratio. This places Minimed Group in the lower half of its industry. The industry median PS Ratio is 2.99. Minimed Group's value of 3.36 is 12.6% above this benchmark. Historically, Minimed Group's own PS Ratio has ranged from 1.86 to 3.53 over the past decade. While the company's 10-year median is 2.66 vs. the industry median of 2.99, Minimed Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.99, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Minimed Group's current PS Ratio of 3.36 is 12.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Minimed Group and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Minimed Group's current PS Ratio is 3.36, which is 26% above median its own 10-year median of 2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (STU:B8S) has a current PS Ratio of 3.36. The current PS Ratio is 3.36, which is 26% above median its 10-year median of 2.66 and 12.6% above the Medical Devices & Instruments industry median of 2.99. Minimed Group's overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Minimed Group (STU:B8S), the current PS Ratio is 3.36 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
20GF Score
Get the complete analysis for STU:B8S
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:B8S has been successfully added to your 
